# Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.

> **NCT05801198** · PHASE2 · NOT_YET_RECRUITING · sponsor: **King Faisal Hospital Rwanda** · enrollment: 125 (estimated)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DIETARY_SUPPLEMENT:** Artemisia afra or Annua 10g oral infusion/tea per day for 14 days

## Key facts

- **NCT ID:** NCT05801198
- **Lead sponsor:** King Faisal Hospital Rwanda
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05801198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05801198, "Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05801198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*